Isikli, Ayse GokceOzkan, Zeynep Kizilcik2024-06-122024-06-1220230965-206X1876-4746https://doi.org/10.1016/j.jtv.2022.10.003https://hdl.handle.net/20.500.14551/18968Aim: This retrospective study aims to determine the impacts of two different products (barrier cream, barrier spray) routinely used before surgery on the development of postoperative pressure injuries in patients under-going lung lobectomy. Materials and methods: In the study, the researchers retrospectively examined the data of 60 patients who un-derwent lobectomy in a university hospital's thoracic surgery clinic between 12.02.2021 and 14.02.2022. The patients were divided into two groups: those to whom a barrier cream was applied (30) and those to whom a barrier spray was applied. The Patient Description Form and the Braden Risk Assessment Tool were used in data collection. The Mann-Whitney U and Kruskal-Wallis tests were conducted for statistical analyses. Results: In the study, the development rates of blanchable erythema and stage I pressure injuries in the sacral and dorsal regions were significantly higher in patients to whom a barrier spray was applied than in patients to whom a barrier cream was applied (p < 0.05). Pain intensity in the sacral and dorsal regions was significantly lower in patients to whom a barrier cream was applied than those to whom a barrier spray was applied (p < 0.05). Conclusion: Blanchable erythema and intraoperative pressure injury were observed less in patients in whom a barrier cream was used before surgery. Surgical nurses should first evaluate the risk in the preoperative period in the clinics and benefit from the use of barrier cream to prevent the development of blanchable erythema and intraoperative pressure injury.en10.1016/j.jtv.2022.10.003info:eu-repo/semantics/closedAccessBarrier CreamBarrier SprayNursing CarePressure InjuryThoracic SurgeryBarrier CreamRisk-FactorsSkinUlcersCareArticle321163167N/AWOS:0009533653000012-s2.0-8514352505036351868Q2